Risk factors for pre‐ and post‐engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation
Authors:
- 12 January 2015
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 17 (1) , 56-65
Abstract
Background: Bloodstream infections (BSI) are frequently observed after allogeneic hematopoietic stem cell transplant (HSCT), and could cause morbidity and mortality.Methods: We retrospectively evaluated the incidence, characteristics of, and risk factors for BSI at both pre‐ and post‐engraftment in 209 adult HSCT patients at our institute between June 2006 and December 2013. The median age at transplantation was 45 years (range, 15–65). A total of 122 patients received bone marrow, 68 received peripheral blood stem cells, and 19 received umbilical cord blood.Results: The cumulative incidences of pre‐ and post‐engraftment BSI were 38.9% and 17.2%, respectively. Nine patients had both pre‐ and post‐engraftment BSI. In the pre‐ and post‐engraftment periods, respectively, 67.4% and 84.1% of isolates were gram‐positive bacteria (GPB), 28.3% and 11.4% were gram‐negative bacteria (GNB), and 4.3% and 4.5% were fungi. Coagulase‐negative staphylococci were the most commonly isolated GPB, while Stenotrophomonas maltophilia and Pseudomonas aeruginosa were the most commonly isolated GNB. Pre‐engraftment BSI was associated with an increased risk of death. Overall survival at day 180 for patients with or without pre‐engraftment BSI was 70.0% and 82.7%, respectively (P = 0.02).Conclusions: Risk factors for BSI in the pre‐engraftment period were the interval between diagnosis and transplantation (261 days or more), engraftment failure, and high‐risk disease status at HSCT in a multivariate analysis. No significant risk factor for BSI in the post‐engraftment period was identified by a univariate analysis. These findings may be useful for deciding upon empiric antibacterial treatment for HSCT recipients.Keywords
This publication has 17 references indexed in Scilit:
- Blood stream infections after allogeneic stem cell transplantation: a single‐center experience with the use of levofloxacin prophylaxisTransplant Infectious Disease, 2011
- Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipientsBone Marrow Transplantation, 2010
- Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associatedBone Marrow Transplantation, 2010
- Blood Stream Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Reemergence of Gram-Negative Rods and Increasing Antibiotic ResistanceTransplantation and Cellular Therapy, 2009
- Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortalityBone Marrow Transplantation, 2007
- Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipientsTransplant Infectious Disease, 2005
- A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in JapanBone Marrow Transplantation, 2004
- Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcomeBone Marrow Transplantation, 2003
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftmentBone Marrow Transplantation, 1998